QL1706 Plus Chemotherapy as Neoadjuvant Therapy in Early High-Risk ER+/HER2- Breast Cancer

Clinical trial NCT06404463 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06404463
Sponsor: Fudan University
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Early Breast Cancer Neoadjuvant Therapy HR+HER2- Breast Cancer

Start date: 2024-05-06
Primary completion: 2025-11-06
Enrollment: 76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.